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Abstract Odanacatib (ODN) is a bone resorption inhib-
itor which differs from standard antiresorptives by its
ability to reduce bone resorption without decreasing bone
formation. What is the reason for this difference? In con-
trast with other antiresorptives, such as alendronate (ALN),
ODN targets only the very last step of the resorption pro-
cess. We hypothesize that ODN may therefore modify the
remodeling events immediately following osteoclastic
resorption. These events belong to the reversal phase and
include recruitment of osteoblasts, which is critical for
connecting bone resorption to formation. We performed a
histomorphometric study of trabecular remodeling in ver-
tebrae of estrogen-deficient rabbits treated or not with
ODN or ALN, a model where ODN, but not ALN, was
previously shown to preserve bone formation. In line with
our hypothesis, we found that ODN treatment compared to
ALN results in a shorter reversal phase, faster initiation of
osteoid deposition on the eroded surfaces, and higher
osteoblast recruitment. The latter is reflected by higher
densities of mature bone forming osteoblasts and an
increased subpopulation of cuboidal osteoblasts. Further-
more, we found an increase in the interface between
osteoclasts and surrounding osteoblast-lineage cells. This
increase is expected to favor the osteoclast–osteoblast
interactions required for bone formation. Regarding bone
resorption itself, we show that ODN, but not ALN, treat-
ment results in shallower resorption lacunae, a geometry
favoring bone stiffness. We conclude that, compared to
standard antiresorptives, ODN shows distinctive effects on
resorption geometry and on reversal phase activities which
positively affect osteoblast recruitment and may therefore
favor bone formation.
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Introduction
Bone diseases, such as osteoporosis and most cancer
metastases to bone, are characterized by loss of bone mass
and increased fracture risk. This is largely due to excessive
bone resorption compared to bone formation during bone
remodeling. These skeletal diseases have triggered the
development of a series of inhibitors of osteoclasts, the cells
responsible for bone resorption. These inhibitors comprise
estrogen, selective estrogen receptor modulators (SERMs),
calcitonin, bisphosphonates such as alendronate (ALN), as
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well as the newly developed denosumab [1]. Although these
antiresorptive drugs are demonstrated to improve bone
mineral density and to reduce fracture risks in patients, they
are also known to reduce bone formation as a consequence
of the coupling between resorption and formation during
bone remodeling. Recent efforts have aimed at finding
alternative treatments based on stimulation of osteoblasts,
the bone forming cells. These have brought intermittent
parathyroid hormone (PTH) therapy onto the market and
anti-sclerostin into clinical trials [2]. However, despite their
clinical efficiency, the bone formation induced by these
anabolic agents is not strictly linked to the sites of bone
resorption, and they may not reestablish the site-specific
bone resorption–bone formation balance that is lost in
pathological bone remodeling [3, 4].
Odanacatib (ODN) is a newly developed inhibitor of
osteoclastic bone resorption presently in a clinical phase III
trial. It is unique compared with the standard antiresorp-
tives because of its ability to inhibit bone resorption while
keeping bone formation generally unaffected or even
stimulated at specific bone sites, as supported by observa-
tions in clinical and preclinical studies with ovariectomized
(OVX) monkeys and rabbits [5–7]. ODN is therefore
considered to represent a new generation of bone resorp-
tion inhibitors that may bring alternative benefits to oste-
oporotic patients compared to the current standard of care.
The mechanism whereby ODN inhibits bone resorption is
well understood [8, 9]; however, how ODN preserves bone
formation requires further investigations.
Osteoclasts remove bone by secreting protons and
cathepsin K, a potent collagen-degrading proteinase [10].
The protons solubilize the mineral, thereby denuding the
collagen fibers, which make up 90 % of the organic bone
matrix. Once denuded, collagen becomes available to
cathepsin K. ODN is a specific inhibitor of cathepsin K and
inhibits thus the resorptive activity of the osteoclast by
inhibiting collagen degradation [8, 9]. This means that ODN
inhibits the very last step of the resorption process, while
other anti-osteoclastic drugs, like bisphosphonates and anti-
RANKL antibody, act more upstream. We speculated that
by uniquely inhibiting this very last step of the resorption
process, ODN could also uniquely modify the signals left in
the resorption lacunae vacated by the osteoclasts and
therefore also modify the cellular events which follow
immediately after osteoclastic resorption, such as osteoblast
recruitment. These events are obviously important in con-
necting bone resorption and formation. We thus hypothe-
sized that ODN might affect bone formation—in contrast to
classical anti-osteoclastic drugs—by acting on this con-
necting step, known as the ‘‘reversal phase’’ [11]. Interest-
ingly, inhibition of cathepsin K by a broad-spectrum
cysteine proteinase inhibitor induced unusual features at the
reversal phase in a mouse model [12], and similar
observations were made in a rabbit model [13] and in py-
cnodysostosis, a disease caused by a mutation in the gene
encoding cathepsin K [12]. It is worth noting that a drug
affecting the reversal phase may be of special relevance to
osteoporosis because this disease is precisely characterized
by a lack of coordination between resorption and formation,
and prolonged or arrested reversal phase has been reported
in estrogen deficiency– and age-related bone loss [11, 14].
Although these reports point to a failure at the level of the
reversal phase, a phase linking resorption and formation has
remained largely undercharacterized [11, 14].
The present study aimed at identifying what differenti-
ates ODN from classical anti-osteoclastic drugs, such as
ALN, in the OVX rabbit model [7]. We histomorphomet-
rically compared their effects on the target cell, the
osteoclast, and on the post–osteoclastic events of the
reversal phase. It is a follow-up of a previous histomor-
phometric study performed on OVX rabbits, where ODN
was shown to differ from ALN in its ability to preserve
bone formation [7]. The recent report on this earlier study
strictly concerned the extent of mineralization surfaces and
bone formation rates and did not show data either on the
resorption or on the reversal phase, which we here
hypothesize to determine the subsequent bone formation
levels.
Materials and Methods
Rabbit Bone Samples
The present study is a follow-up of the recent study reported
by Pennypacker et al. [7]. In brief, 6-month-old female
rabbits were randomized into four groups: (1) sham-operated
(n = 11), (2) OVX and treated with vehicle (n = 12), (3)
OVX and treated subcutaneously with ALN (300 lg/kg
twice/week, n = 11), and (4) OVX and treated orally with
ODN given in a control diet (Teklad global high fiber 2031C;
Harlan, Indianapolis, IN) at a concentration of 0.0016 % (w/
w) corresponding to a steady-state exposure of AUC =
4 lM/24 h of ODN (n = 12). Since the plasma protein
binding is lower in the rabbit (87.3 %) than in humans
(97.5 %), the free fraction of ODN exposure in this study was
0.51 lM/24 h, or approximately threefold of the human
daily free fraction calculated from the 50-mg once-weekly
clinical dose (6–7 lM/24 h). Treatment of the rabbits was
started on the third day after ovariectomy and continued for
27 weeks, after which the animals were killed. For histo-
morphometry, lumbar vertebra L4 was removed, immersed
in 70 % ethanol, and embedded undecalcified in 80 %
methyl methacrylate–20 % dibutyl phthalate. For immuno-
histochemistry, bone specimens (L2) were obtained from a
new study including three rabbits in each of the four groups.
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The four groups were treated as described above except for
the ODN group, which was treated orally in the control diet at
a concentration of 0.0043 % (w/w) corresponding to a
steady-state exposure of AUC = 7.5 lM/24 h of ODN, and
the ALN group, which was treated once weekly at a dose of
300 lg/kg. Bone specimens were fixed in 4 % formalde-
hyde, decalcified in 0.2 M EDTA-Na2 containing 0.05 %
formaldehyde, and embedded in paraffin.
Histochemistry and Immunohistochemistry
Paraffin sections (3.5 lm thick) from L2 were processed for
toluidine blue (1 %), tartrate-resistant acid phosphatase
(TRAP) activity, and immunohistochemical stains. Tolui-
dine blue staining was performed as previously described
[6]. TRAP activity staining was done as described by van de
Wijngaert and Burger [15], sections were counterstained
with Mayer’s hematoxylin and mounted. For immunohisto-
chemistry, the procedure included deparaffinization and
rehydration of the sections, followed by epitope retrieval in
Tris–EDTA buffer (pH 9.0) overnight at 60 C. Immuno-
stainings for cathepsin K were performed using a polyclonal
goat IgG antibody (sc-6507; Santa Cruz Biotechnology,
Santa Cruz, CA, USA) as primary antibody and a mouse anti-
goat IgG (Jackson ImmunoResearch Laboratories, West
Grove, PA, USA) as secondary antibody. The mouse anti-
goat IgGs were detected with a polymeric alkaline phos-
phatase–conjugated system (PowerVision; ImmunoVision
Technologies, Hillsborough, CA, USA) and visualized by
liquid permanent red (DakoDenmark, Glostrup, Denmark).
Sections were counterstained with Mayer’s hematoxylin and
mounted.
Histomorphometry and Electron Microscopy
Histomorphometric parameters were assessed in the can-
cellous bone of Masson-Goldner trichrome–stained sec-
tions (6 lm) prepared from the plastic-embedded L4 as
described [7]. The parameters included the trabecular bone
volume per tissue volume (BV/TV), trabecular thickness
(Tb.Th), trabecular number (Tb.N), trabecular spacing
(Tb.Sp), as well as the fraction of trabecular bone surface
covered by eroded (ES/BS), osteoclast (Oc.S/BS), reversal
(Rv.S/BS), osteoid (OS/BS), and osteoblast surface (Ob.S/
BS). Reversal surfaces were defined as eroded surfaces
(identified through broken lamellae) without osteoclasts.
For every single hit on reversal perimeters the presence of
osteoid in the vicinity was recorded. Vicinity was defined
as being within the same 2D remodeling unit as the reversal
surface itself. Furthermore, discrimination was made
between cuboidal (C.Ob.S) and flat osteoblasts based on
the cell morphology. Cuboidal osteoblasts were defined as
cells with a cuboidal or plumb shape lining osteoid, and flat
osteoblasts were defined as cells with a flat nucleus and
thin cytoplasm lining osteoid. The trabecular bone volume,
trabecular thickness, trabecular number, and trabecular
spacing were measured at a total magnification of 1009
using the Osteomeasure Analysis System (OsteoMetrics,
Decatur, GA, USA), whereas all other histomorphometric
analyses were done in a systematic random way at a total
magnification of 2009 using a light microscope (DM2500;
Leica, Herlev, Denmark) equipped with an eyepiece con-
taining a Merz graticule with parallel curved lines [16].
Osteoclasts were characterized in more detail in Mas-
son-Goldner trichrome– and toluidine blue–stained sec-
tions. The total number of osteoclast profiles in the
cancellous area of the vertebral body was assessed in
Masson-Goldner trichrome–stained sections from each
rabbit. Discrimination was made between profiles of
osteoclasts attached to the bone matrix and profiles of
osteoclasts detached from the bone matrix. Profiles of
detached osteoclasts were categorized as either osteoclast
profiles separated from the bone surface by a layer of
mononucleated cells or osteoclast profiles found farther
away from the bone surface, i.e., more than one cell layer
from the bone surface or above bone forming osteoblasts.
Regarding the attached osteoclast profiles, discrimination
was made between profiles found in resorption cavities
more than two lamellae deep and profiles found on none-
roded or shallow cavities, i.e., less than or equal to a depth
of two lamellae. This analysis was done at a total magni-
fication of 2009 using a light microscope (Leica
DMRXAZ), where broken lamellae were visualized by
polarized light. The presence of demineralized collagen at
the osteoclast–bone interface and the presence of intra-
cellular vesicles in osteoclasts were analyzed in Masson-
Goldner trichrome– and toluidine blue–stained sections,
respectively, at a total magnification of 4009.
Cell densities of reversal cells and osteoblasts were
measured at a total magnification of 4009 using the Os-
teomeasure Analysis System (OsteoMetrics). Here, all cell
profiles connected to the bone surface were counted
regardless of the presence of a visible nucleus. Samples for
electron microscopic analysis were prepared as previous
described [17] and analyzed with a transmission electron
microscope (TEM 208; Philips, Eindhoven, The Nether-
lands) operated at 80 kV.
Statistical Analysis
Data for each group were tested for normality using the
D’Agostino-Pearson omnibus test. When the data allowed
for parametric statistics, the unpaired t-test was used,
applying the Welch correction in the presence of unequal
variances. When nonparametric statistics were needed, the
Mann–Whitney test was used. The correlation between two
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variables was analyzed using the Spearman rank correla-
tion test. Best-fitted lines were made by linear regression
including a comparison of the slopes of the regression
lines. p \ 0.05 was considered statistically significant. All
statistical analyses were performed with GraphPad Prism 5
(GraphPad Software, La Jolla, CA,USA).
Results
Effects of OVX and ODN or ALN on Structural Indices
of Trabecular Bone
In agreement with other reports [18, 19], OVX significantly
reduced bone volume and trabecular numbers, significantly
increased trabecular space, and did not affect trabecular
thickness, thus supporting estrogen deficiency–induced
bone loss (Table 1). According to the present measure-
ments, ALN or ODN treatment of OVX rabbits induced
thicker trabeculae but did not prevent either the reduction
in trabecular number or the increase in trabecular space, as
was also reported in OVX monkeys treated with ODN [20].
Effects of ODN and ALN on Osteoclasts and Bone
Resorption in OVX Rabbits
Since both ODN and ALN target the osteoclast, we per-
formed a systematic analysis of the extent of bone surface
covered by eroded surface and by osteoclasts. Vehicle-
treated OVX rabbits (OVX ? Veh) did not demonstrate
any significant changes in the extent of eroded surface or
osteoclast surface compared to the sham group (Fig. 1),
which is consistent with other long-term OVX studies [19].
Treatment of OVX rabbits with ODN resulted in a twofold
increase in the extent of eroded surface and a threefold
increase in osteoclast surface, whereas ALN did not induce
any significant changes in these parameters. These obser-
vations are consistent with earlier reports on ODN effects
in monkeys [6, 21] and on ALN effects in multiple species
[22–24].
Because osteoclasts responded differently to ODN and
ALN, a more thorough examination of the treatment-
related effects on osteoclasts was undertaken. Osteoclast
profiles were generally found in contact with the bone
surface in the OVX ? Veh group (Fig. 2a). Although this
was also the case for the majority of the osteoclast profiles
in the ALN- and ODN-treated OVX rabbits, a substantial
proportion of the profiles appeared detached from the bone
surface (Fig. 2a, b). Upon quantification, the proportion of
detached osteoclast profiles proved to be increased sixfold
in ALN- and threefold in ODN-treated OVX rabbits
compared to vehicle-treated OVX rabbits (Fig. 3a). The
proportion of detached osteoclast profiles was thus two
times higher in the group receiving ALN than in the group
receiving ODN (Fig. 3a). Further analysis on the detached
osteoclast profiles revealed that more than half of these
profiles in sham, vehicle-, and ODN-treated OVX rabbits
were separated from the bone surface by a single layer of
mononucleated cells, i.e., reversal cells, which were found
directly interposed between the osteoclast itself and the
bottom of the resorption cavity (Figs. 2b, 3b). In contrast,
the fraction of osteoclast profiles showing this type of
contact with reversal cells was two times lower in the
ALN versus ODN treatment. Instead, in the presence of
ALN, the detached osteoclast profiles were more fre-
quently found at C2 cell layers away from the bone sur-
face or even above bone forming osteoblasts (Figs. 2a,
3b), thus suggesting that ALN treatment changes the
adhesion and function of the osteoclasts more dramatically
than ODN.
Another unique effect of ODN concerns the bone in
contact with osteoclast profiles. In ODN-treated OVX
rabbits, osteoclasts appeared about twice as frequently on
noneroded surfaces or shallow cavities (B2 lamellae deep)
compared to the situation in the other groups, including
ALN treatment (Figs. 2c, 3c). Hence, even though ODN
treatment leads to an increased extent of osteoclast and
eroded surfaces, erosion is not deep and the total amount of
resorbed bone matrix should not necessarily be as signifi-
cant as suggested by the extent of eroded surfaces.
Table 1 Effects of OVX, ALN and ODN on structural indices of trabecular bone
Group n BV/TV (%) Tb.Th (lm) Tb.N (#/mm) Tb.Sp (lm)
Sham 11 15 ± 3 102 ± 14 1.7 (1.3, 2.2) 456 (342, 628)
OVX ? veh 12 11 ± 2** 101 ± 14 1.2 (1, 1.5)* 726 (576, 912)*
OVX ? ALN 11 15 ± 5 124 ± 26*  1.3 (1.1, 1.6)* 688 (511, 783)*
OVX ? ODN 12 12 ± 3 121 ± 16**  1.2 (0.9, 1.5) 735 (554, 1049)
BV/TV and Tb.Th are expressed as mean values ± SD and Tb.N and Tb.Sp as median values, where the first number in parentheses is the first
quartile and the second number is the third quartile
* p \ 0.05 against sham, ** p \ 0.01 against sham,  p \ 0.05 against OVX ? veh,  p \ 0.01 against OVX ? veh
OVX ovariectomy, ALN alendronate, ODN odanacatib, BV/TV bone volume/total volume, Tb.Th trabecular thickness, Tb.N trabecular number,
Tb.Sp trabecular spacing
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Staining of undegraded, demineralized collagen fre-
quently appeared at the osteoclast–bone interface in ODN-
treated OVX rabbits (Figs. 2d, 3d), as was previously
demonstrated in mouse and rabbit bones treated with a
broad-spectrum cysteine proteinase inhibitor [12, 13].
Furthermore, ODN treatment induced an accumulation of
toluidine blue–stained intracellular vesicles in osteoclasts
(Figs. 2e, 3e), as reported earlier in ODN-treated monkeys
and interpreted as accumulation of collagen fragments [6].
No stained vesicles were observed in sham, vehicle-, or
ALN-treated OVX rabbits (Fig. 3e). These observations
thus indicate compromised extracellular and intracellular
degradation of demineralized collagen in the presence of
ODN, in line with earlier reports on the effect of cathepsin
K inhibition [8, 12, 25].
Interestingly, the immunoreactivity of cathepsin K
appeared to be increased in ODN-treated OVX rabbits
compared to sham, vehicle-, and ALN-treated OVX rabbits
(Fig. 2f), which suggests that increased expression/intra-
cellular accumulation of cathepsin K is induced by ODN
treatment. This observation is consistent with earlier obser-
vations obtained in various experimental systems [8, 26, 27].
Effects of ODN and ALN Treatment on the Reversal
Phase
The reversal surfaces are defined as eroded surfaces vacated
by osteoclasts [11]. They are the surfaces that physically
connect bone resorption to formation, meaning that they may
play a critical role in the initiation of bone formation during
bone remodeling. Because ODN and ALN affect osteoclasts
differently, it is important to analyze whether this difference
has an impact on the reversal phase. We first analyzed the
extent of reversal surfaces in the four groups of rabbits
(Fig. 4a). Ovariectomy of the rabbits (OVX ? Veh) had no
significant effect on the extent of reversal surfaces compared
to sham. Compared to OVX ? Veh rabbits, ODN treatment
increased the extent of reversal surface more than twice,
whereas ALN treatment induced a widespread distribution of
the values, with no significant effect being found (Fig. 4a).
Furthermore, when relating the extent of reversal surface to
the extent of osteoclast surface measured in each biopsy, a
clear positive correlation was observed in all groups,
meaning that the more bone surface is covered by osteo-
clasts, the larger is the extent of reversal surfaces (Fig. 4b).
Interestingly, however, as indicated by the slope of the
regression lines, the increases in reversal surface were sig-
nificantly smaller in the ODN group compared with all of the
other groups, suggesting that osteoid deposition starts
sooner. In line with this, reversal surfaces were more than
twice as frequently close to osteoid surfaces in the presence
of ODN than in the presence of ALN (Fig. 4c). Furthermore,
compared to all of the other groups, cell densities on the
reversal surfaces tended to increase in ODN-treated OVX
rabbits, which was the only group showing a significantly
increased reversal cell density compared with sham
(Fig. 4d). Altogether these observations indicated that ODN
and ALN affected the reversal phase differently and thereby
also the connection of resorption and formation. Thus,
compared to ALN, ODN appeared to allow higher bone
surface cell densities and a faster initiation of the bone for-
mation step during bone remodeling.
Effects of ODN and ALN Treatment on Bone
Formation Parameters
In the previous report on the comparative effects of ODN
and ALN in OVX rabbits [7], mineralizing surfaces and
Fig. 1 Effect of odanacatib (ODN) and alendronate (ALN) treatment
on bone resorption parameters in ovariectomized (OVX) rabbits. The
extent of eroded surface (ES/BS) and osteoclast surface (Oc.S/BS) was
assessed in the vertebral trabecular bone of sham and OVX rabbits
treated with vehicle (Veh), ALN, or ODN. The results are shown as
means with SD a or as medians with upper and lower quartiles
b. Differences between the groups were analyzed by the Mann–
Whitney test b or the t-test a, applying Welch correction in the
presence of unequal group variances. *p \ 0.05, **p \ 0.01,
***p \ 0.001
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bone formation rates were shown to increase in response to
OVX and to be higher upon treatment of the OVX rabbits
with ODN compared with ALN. Here, we analyzed addi-
tional bone formation parameters. Figure 5(a, b) shows that
the extent of osteoid and osteoblast surfaces also increased
in response to OVX but that they were not changed upon
further treatment with ODN or ALN. In this respect, one
should note that the measurements in the ALN group were
widely distributed, with values ranging from approximately
2–87 %, thus revealing variable effects of ALN on the
extent of osteoid and osteoblast surfaces.
Interestingly, however, a more detailed analysis dem-
onstrated clearly distinct effects of ODN and ALN on
osteoblasts. Compared with ALN, ODN led to a threefold
higher prevalence of cuboidal osteoblasts (Fig. 5c), a
morphology reflecting a higher cell density. In line with
Fig. 2 Histological appearance of osteoclasts in odanacatib (ODN)–
and alendronate (ALN)–treated ovariectomized (OVX) rabbits. a Mas-
son-Goldner trichrome staining shows the appearance of osteoclast
profiles (asterisks) attached to the vertebral trabecular bone surface
from a vehicle-treated (left panel) and an ALN-treated (middle panel)
OVX rabbit. Osteoclast profiles frequently appeared away from the
bone surface in ALN-treated OVX rabbits as shown by the presence
of a giant osteoclast (asterisk) above bone forming osteoblasts (right
panel). b Examples of osteoclast profiles (asterisks) detached from
the bone surface by mononucleated reversal cells (Rv.C, arrows) in an
ODN-treated OVX rabbit as they appear using Masson-Goldner
trichrome staining (left panel), TRAP activity staining (middle panel),
and electron microscopy (right panel). c TRAP-positive osteoclast
profiles (asterisks) attached to a bone surface without visible broken
lamellae. The framed area in the left panel is enlarged in the right
panel. d Example of an osteoclast profile (asterisk) with demineral-
ized collagen below (arrowheads), visualized by Masson-Goldner
trichrome staining. e Toluidine blue staining showing the absence and
presence of intracellular vesicles in osteoclast profiles (asterisks) in
the vertebral trabecular bone from an ALN-treated (left panel) and an
ODN-treated (right panel) OVX rabbit. f Immunohistochemical
staining showing elevated intracellular levels of cathepsin K in
trabecular osteoclasts (asterisks) of ODN-treated OVX rabbits (right
panel) compared to ALN-treated (middle panel) and vehicle-treated
(left panel) OVX rabbits. Scale bar = 50 lm, except for b, right
panel = 10 lm and c, left panel = 200 lm
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this observation, ODN also led to significantly higher
osteoblast densities compared with both ALN-treated and
sham rabbits (Fig. 5d). Thus, overall, the higher prevalence
of cuboidal osteoblasts and the higher osteoblast density
may contribute to the increased mineralizing surfaces and
bone formation rates observed upon ODN treatment com-
pared with ALN treatment [7].
Discussion
It is well known that ODN and ALN have in common to be
inhibitors of osteoclastic bone resorption, but that ODN
differs from ALN and other traditional antiresorptives by
its ability to preserve bone formation. The present study
emphasizes a series of additional distinctive properties of
ODN. These relate to bone resorption itself, the reversal
phase, and osteoblast recruitment. Interestingly, the effects
of ODN on the latter two shed insight into how ODN may
favor bone formation.
Regarding resorption, our data show that treatment with
ODN clearly changes the geometry of the resorption cav-
ities compared to controls and a classical antiresorptive,
ALN. Upon ODN treatment, a larger surface is eroded but
erosion is less deep. The latter characteristic is in accor-
dance with the repeated demonstration of shallower exca-
vations in the pit assay in response to lowered levels of
cathepsin K activity [28–31]. It is of interest that ODN
Fig. 3 Effects of odanacatib
(ODN) and alendronate (ALN)
treatment on osteoclast features.
a The extent of osteoclast
profiles detached from the bone
surface was evaluated in the
vertebral trabecular bone of
sham and ovariectomized
(OVX) rabbits treated with
vehicle (Veh), ALN, or ODN.
Data are expressed as the
percentage of detached
osteoclast profiles per total
number of osteoclast profiles.
b Among the osteoclast profiles
detached from the bone surface,
some covered tightly reversal
cells (Rv.Cs). The fraction of
this population of osteoclasts is
expressed as percentage of the
total detached osteoclasts.
c Percentage of osteoclast
profiles attached onto bone
surfaces with an erosion depth
of B2 lamellae. d Percentage of
osteoclast profiles with
demineralized collagen below.
e Percentage of osteoclast
profiles with intracellular
vesicles. Results are shown as
medians with upper and lower
quartiles a or as means with SD
b–e. Rabbits with fewer than 20
osteoclast profiles were
excluded from the analyses.
Differences between groups
were analyzed by the Mann–
Whitney test a or the t-test b–e,
applying the Welch correction
in the presence of unequal group
variances. *p \ 0.05,
**p \ 0.01, ***p \ 0.001
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thereby mimics the effect of estrogen, which reduces both
cathepsin K expression [32, 33] and the depth of the pits
[30]. As discussed by the latter authors, a shallower
geometry may help in preventing perforations of trabecu-
lae; and it was also shown to favor bone stiffness [34].
Thus, a unique property of ODN is to allow bone remod-
eling while simply reducing its rate and changing the
geometry of the package of matrix, which is renewed with
less risk of fragilization. This effect on geometry is prob-
ably a result of ODN slowing down collagen degradation
without directly affecting demineralization. The rate of
collagen degradation relative to the rate of demineraliza-
tion is a major determinant of the shape of the resorption
lacunae, as discussed by Soe et al. [35]. It should be noted
that others also reported that ALN has no effect on erosion
depth [23].
The reversal phase has been proposed to prepare the
eroded bone surfaces for bone formation [12], and reversal
phase arrest prevents subsequent bone formation [11, 12,
14]. The reversal phase is thus a key for successful
remodeling. As explained below, ODN shows unique
effects on the reversal phase compared to ALN and control:
(1) it shortens it, thus shortening the duration between the
end of resorption and the initiation of bone deposition, and
(2) it favors osteoblast recruitment.
In earlier studies, the duration of the reversal phase was
estimated by relating the extent of the reversal surface to
the extent of the osteoclast surface, and it was shown that
reversal surfaces relative to osteoclast surfaces were
smaller in situations where resorption is known to be ide-
ally coupled with formation, like in primary hyperpara-
thyroidism [11, 14]. In contrast, it was shown to be larger
Fig. 4 Effect of odanacatib (ODN) and alendronate (ALN) treatment
on the reversal phase. a The extent of reversal surface (Rv.S/BS) was
assessed in the trabecular bone of a vertebra of sham and OVX rabbits
treated with vehicle (Veh), ALN, or ODN. b The Rv.S shown in a was
plotted against the Oc.S/BS shown in Fig. 1 in order to evaluate the
relationship between osteoclast and reversal phase prevalence for
each rabbit. Each dot represents the measurement obtained in a bone
specimen isolated from one rabbit (sham: black circles, black dotted
line; OVX ? Veh gray open squares, gray dotted line; OVX ? ALN
gray diamonds, gray line; OVX ? ODN black triangles, black line).
c The proximity of the reversal surfaces to formative surfaces is
shown for each group as the percentage of Rv.S with OS in the
vicinity as defined in ‘‘Materials and Methods.’’ d The density of
mononucleated cells on the reversal surfaces, i.e., reversal cells
(Rv.C), is shown for each of the four groups of rabbits in cell profiles
per millimeter. Results are shown as means with SD a, d or medians
with upper and lower quartiles c. The Mann–Whitney c or the t-test a,
d was used to analyze whether the parameters were significantly
different in the four groups, and correlations between the extent of
Oc.S/BS and Rv.S/BS b were analyzed using the Spearman rank
correlation test, *p \ 0.05, **p \ 0.01, ***p \ 0.001. The lines in
b were made by linear regressions. Comparison of the slopes of the
regression lines for sham, OVX ? Veh, and OVX ? ALN revealed
no differences. Therefore, the slope of the best-fitted regression line
for the pooled groups (line not shown, Spearman rank correlation for
pooled groups rs = 0.80, p \ 0.0001) was compared with the slope of
the regression line for OVX ? ODN and proved to be significantly
different (p = 0.0012)
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in situations of less efficient coupling, like in osteoporosis
[11, 14]. In the present study, the ODN-induced shortening
of the reversal surface relative to the osteoclast surface thus
points to an efficient coupling and faster initiation of bone
formation in the presence of ODN compared to all other
conditions investigated here. This interpretation is sup-
ported by the fact that bone deposition is more frequently
seen in the neighborhood of reversal surfaces upon ODN
treatment than in all the other conditions.
A major event occurring during the reversal phase is
recruitment of osteoblasts to the bone surface. It should be
noted that the result of this process is not well reflected by
the extent of osteoblast surface since osteoblast-lineage
cells may spread to a variable extent over the bone surface,
where they may adopt either a flat or a cuboidal mor-
phology. The result of osteoblast recruitment is thus better
appreciated through cell density. Here, we show that ODN
treatment favors higher osteoblast densities and more
cuboidal osteoblasts compared to ALN treatment. It makes
sense to believe that this higher cell density would result in
higher bone formation rates and mineralizing surfaces, as
previously reported by Pennypacker et al. [7]. Interestingly,
cell densities appeared already higher at the level of the
reversal phase, which is in accordance with the view that
reversal cells may differentiate into mature osteoblasts.
What is the mechanism whereby ODN treatment affects
the reversal phase? Here, two issues should especially be
emphasized. First, the signals left by the osteoclast in the
resorption lacuna are probably also the signals seen by the
cells colonizing these lacunae after the departure of the
osteoclast. Since ODN acts on the very last step of the
resorption process, ODN treatment is likely to affect these
signals. Obvious changes due to the presence of ODN are
less efficient degradation of organic matrix molecules, thus
resulting in the accumulation of demineralized collagen; of
other bone matrix molecules [25]; as well as of matrix-
associated growth factors [36]. Collagen and growth fac-
tors, like transforming growth factor-b, have been shown to
be chemoattractants for osteoblast-lineage cells [37, 38].
Furthermore, electron microscopic studies of mouse and
rabbit bone cultures performed in the presence of cathepsin
K inhibitors showed numerous osteoblast-lineage cells in
close contact with osteoclasts and enwrapping the demin-
eralized collagen fibers that the osteoclasts themselves
were unable to degrade [12, 13]. The same osteoblast-
lineage cells were also shown to deposit cement lines and
collagen fibers in the vacated pits [12, 39]. Here, we have
extended these studies in several ways: we used a selective
cathepsin K inhibitor, ODN; we quantified the interactions
of the osteoclasts with the periosteoclastic cells; and we
showed that ODN favors these interactions compared to
ALN. Taking these observations together, a likely scenario
contributing to increased osteoblast recruitment is that
collagen leftovers and undegraded growth factors stimulate
the recruitment and the activity of the cells colonizing the
vacated resorption lacunae, which are the cells that
Fig. 5 Effect of odanacatib
(ODN) and alendronate (ALN)
treatment on bone formation
parameters. The extent of
osteoid surface (OS/BS) a, total
osteoblast surface (Ob.S/BS) b,
and cuboidal osteoblast surface
(C.Ob.S/BS) c was evaluated in
a vertebra from the sham and
OVX rabbits treated with
vehicle (Veh), ALN, or ODN.
d The density of osteoblasts
(cell profiles per millimeter) is
shown for each of the four
groups. Results are shown as
medians with upper and lower
quartiles a–c or means with SD
d. The Mann–Whitney a–c or
the t-test d was used to analyze
whether the parameters were
significantly different in the four
groups. *p \ 0.05, **p \ 0.01
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subsequently differentiate into mature bone forming
osteoblasts.
In relation with the mechanism whereby ODN affects the
reversal phase and bone formation, one should also empha-
size the impressive increase in osteoclast surface induced by
ODN. Several other situations of increased osteoclast surface
have been reported, which include impairment of c-Src and
chloride channel 7 (ClC-7) activity [40, 41]. Interestingly, all
these situations have been associated with increased bone
formation [41, 42]. This effect is poorly understood and has
led to the proposal that osteoclastic anabolic factors might be
involved [43]. One may also note that all these situations,
including the ODN-induced increase in osteoclast preva-
lence, lead to an increase in the interface between osteoclasts
and all cells surrounding the osteoclasts. Among the latter
cells are not only reversal cells, as discussed above, but also
(1) bone remodeling compartment canopy cells, which are
osteoblast-lineage cells and likely contribute to the forma-
tion of mature bone forming osteoblasts [16, 44], and (2)
endothelial cells, which appear also to be involved in bone
formation during remodeling of cancellous bone [17]. The
contributions of canopy and endothelial cells should be
assessed in future investigations.
It is interesting that in the present model the positive
effects of ODN and ALN on bone formation result in
increased trabecular thickness but not in prevention of
OVX-induced loss of trabeculae, as also reported else-
where [20]. Therefore, the observations reported here may
concern surviving trabeculae, which have been found to
correspond with the trabeculae submitted to strain [45].
One should thus be aware that the ODN effects reported in
the present study might be conditioned by mechanical
loading.
In conclusion, so far treatments of bone diseases have
focused mainly on bone resorption itself or bone formation
itself. However, bone diseases may not simply be due to a
direct failure of resorption or formation but result from a
lack of coordination between resorption and formation.
Here, we propose that ODN is a bone resorption inhibitor
which acts positively on the mechanism coordinating
resorption with formation, through recruitment of osteoblast
progenitors.
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